Upstream / Downstream

Explore pathways related to this product.

Our U.S. Offices Are Closed

Our U.S. offices are closed in observance of Thanksgiving. We will reopen on Monday, December 1st.

Thank you for your patience.

To Purchase # 8901SC

8901SC 100 µg (With Carrier) $269.00
8901SF 100 µg (Carrier Free) $269.00
$ 0. 00

Questions?

Find answers on our FAQs page.

ANSWERS  

Visit PhosphoSitePlus®

PTM information and tools available.

LEARN MORE

Source / Purification

Recombinant human IFN-γ (hIFN-γ) Gln24-Gln166 (Accession # NM_000619) was produced in E. coli at Cell Signaling Technology.

Product Description

Purity:

>96% as determined by SDS-PAGE of 6 μg reduced (+) and non-reduced (-) recombinant hIFN-γ. All lots are greater than 96% pure.


Molecular Formula:

Recombinant hIFN-γ has a Met on the amino terminus and has a calculated MW of 16,907. DTT-reduced and non-reduced protein migrate as 17 kDa polypeptides. The expected amino-terminus MQDPY of recombinant hIFN-γ was verified by amino acid sequencing.


Bioactivity:

The bioactivity of hIFN-γ was determined in a virus protection assay. The ED50 of each lot is between 0.30-1.2 ng/ml.


Endotoxin:

Less than 0.01 ng endotoxin/1 μg hIFN-γ.


Product Usage Information

Formulation:

With carrier: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 containing 20 μg BSA per 1 μg hIFN-γ. Carrier free: Lyophilized from a 0.22 μm filtered solution of PBS, pH 7.2 with trehalose.


Storage: Stable in lyophilized state at 4°C for 1 year after receipt. Sterile stock solutions reconstituted with carrier protein are stable at 4°C for 2 months. Maintain Sterility. Do not store frozen.

IFN-γ plays key roles in both the innate and adaptive immune response. IFN-γ activates the cytotoxic activity of innate immune cells such as macrophages and NK cells (1,2). IFN-γ production by NK cells and antigen-presenting cells (APCs) promotes the cell mediated adaptive immunity by inducing IFN-γ production by T lymphocytes, increased class I and class II MHC expression, and enhancing peptide antigen presentation (1). The anti-viral activity of IFN-γ is due to its induction of PKR and other regulatory proteins. Binding of IFN-γ to the IFNGR1/IFNGR2 complex promotes dimerization of the receptor complexes to form (IFNGR1/IFNGR2)2 -IFN-γ dimer. Binding induces a conformational change in receptor intracellular domains and signaling involves Jak1, Jak2 and Stat1 (3). The critical role of IFN-γ in amplification of immune surveillance and function is supported by increased susceptibility to pathogen infection by IFN-γ or IFNGR knockout mice and in humans with inactivating mutations in IFNGR1 or IFNGR2. IFN-γ also appears to have a role in atherosclerosis (4).


1.  Schroder, K. et al. (2004) J Leukoc Biol 75, 163-89.

2.  Martinez, F.O. et al. (2009) Annu Rev Immunol 27, 451-83.

3.  Kotenko, S.V. et al. (1995) J Biol Chem 270, 20915-21.

4.  McLaren, J.E. and Ramji, D.P. (2009) Cytokine Growth Factor Rev 20, 125-35.


Entrez-Gene Id 3458
Swiss-Prot Acc. P01579


For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology® is a trademark of Cell Signaling Technology, Inc.